Filtering by:
Basal and Squamous Cell Skin CancerFDA Approves Libtayo (Cemiplimab) for a Type of Skin Cancer
The US Food and Drug Administration (FDA) has approved Libtayo (cemiplimab) to treat people with advanced squamous cell carcinoma of the skin.
25-Year Multiple Myeloma Survivor Rides for Hope
Multiple myeloma survivor Jim Bond is easy to spot among the hundreds of bicyclists in the Pan Ohio Hope Ride, which takes place every July and raises money for the American Cancer Society.
Sun Protection Becomes Priority for Survivor of Basal Cell Carcinoma
Basal cell carcinoma survivor Bonneda Kallan, 44, says if she could go back in time, she’d make some different choices to avoid damaging her skin.
FDA Approves Odomzo (Sonidegib) for Basal Cell Skin Cancer
The US Food and Drug administration (FDA) has approved Odomzo (sonidegib) for certain people with basal cell carcinoma, the most common type of skin cancer.
Skin Cancer Survivor Says, ‘Love the skin you’re in.’
Skin cancer survivor Cathey Gray has not seen the inside of a tanning bed since last summer. Before that, for about 7 years, she tanned her skin in a tanning bed almost every day.
Vitamin D Holds Skin Cancer Drug Potential
Early research funded by the American Cancer Society suggests a form of vitamin D could be key to developing drugs for basal cell carcinoma, the most common type of skin cancer.
